Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

Infant Formula Clinical Trial

Official title:
Gastrointestinal Tolerability of a Partially Hydrolyzed, Whey-based, Ready-to-feed Infant Formula in Healthy Newborns During the Birth Hospitalization Period: a Post-market Study

Status Completed

Clinical Trial Summary

Gastrointestinal tolerability of a partially hydrolyzed, whey-based, ready-to-feed infant formula in healthy newborns during the birth hospitalization period: a post-market study

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Infant Formula
Infant Nutritional Physiological Phenomena

Clinical Trial Details

NCT number	NCT05097924
Study type	Observational
Source	Nestlé
Contact
Status	Completed
Phase
Start date	February 1, 2022
Completion date	March 9, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05578716` - Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula	N/A
Completed	`NCT00340665` - Study of Infant Diets on Estrogen Activity and Development
Not yet recruiting	`NCT06318117` - Reason for Prescribing Rice Infant Formula
Completed	`NCT05224947` - Gastric Layering and Monitoring II	N/A
Completed	`NCT01625273` - Supplementation of Infant Formula With Synbiotics	N/A
Recruiting	`NCT05992493` - The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
Completed	`NCT03456934` - Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease	N/A
Recruiting	`NCT05868408` - Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants	N/A
Completed	`NCT05295030` - Effects of Breast Milk Simulated Infant Formula	N/A